Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

In this case study, researchers reported that moth-eaten alopecia was the only clinical sign of secondary syphilis in a 28-year-old man from Nepal, and treatment with Benzathine Penicillin G led to complete hair regrowth within four months.

This case study reports a 26-year-old male with secondary syphilitic alopecia misdiagnosed as alopecia areata, likely contracted through non-penetrative sexual contact. Effective treatment with intramuscular benzathine penicillin G led to complete hair regrowth within three months.

This report details a rare case of late latent syphilis in a 17-year-old male with unusual symptoms like polyarthritis and hair loss, which resolved following antibiotic treatment, highlighting varied syphilis presentations and the importance of STI screening, especially in high-risk groups.

In this case study, a woman with secondary syphilis showed significant improvement following treatment with benzyl penicillin potassium, as evidenced by a 3.7-fold decrease in rapid plasma reagin levels.

This case report describes a 35-year-old Taiwanese man whose hair loss improved significantly after treatment for syphilis, suggesting a link between his condition and the infection.

This case report highlights a patient whose essential syphilitic alopecia was the only symptom of syphilis, which improved after benzathine penicillin treatment, emphasizing alopecia as a potential sign of syphilis.

This article provides no abstract or new research findings.

This case study details a 31-year-old woman diagnosed with secondary syphilis that presented with chronic headaches and hair loss, ultimately attributed to neurosyphilis and alopecia syphilitica.

This case study reports a 22-year-old homosexual man coinfected with secondary syphilis, condyloma acuminata, and HIV, highlighting the coexistence and increased STI risks associated with HIV and HPV infection.

This study confirmed that a sulfotransferase enzyme test can effectively rule out 95.9% of nonresponders to 5% topical minoxidil for treating androgenetic alopecia.

This review discusses syphilis and reports no new clinical findings; it highlights the need for improved prevention and diagnosis to address increasing infection rates globally and in Hungary.

This guideline reviews the diagnosis of androgenetic alopecia and offers expert consensus recommendations tailored to males, females, and adolescents, but reports no new clinical results.

This review discusses the classifications, diagnostic methods, and treatment strategies for female pattern hair loss, but reports no clinical results.

This review discusses diagnostic approaches for women with diffuse, nonscarring hair loss and reports no new clinical results.

In this study, acne severity in females was strongly associated with inflammatory lesion count and moderately associated with androgens, especially DELTA 4 and DHEAS promoting acne and SHBG reducing it.

This review discusses a clinical approach to diagnosing alopecia through patient history and clinical findings, but it reports no new clinical results.

This article reviews the relationship between hair loss and lithium but does not provide any new clinical findings.

This article discusses the late presentation of myotonic dystrophy but reports no new clinical findings.

This case report noted that HIV-infected men who have sex with men are at a higher risk of syphilis, requiring careful staging and prolonged serologic monitoring to assess treatment success.

This review discusses skin diseases related to contraceptive use, reporting potential issues with oral contraceptives and infrequent reactions to mechanical or barrier methods without new clinical findings.

This article discusses expert responses to hair loss in women but reports no new research findings.

This study examined serum PSA levels in women with androgenetic alopecia to evaluate their potential as a marker for androgen effects on target organs.

This article discusses the history taking and clinical examination process for diagnosing alopecia and outlines a diagnostic approach, noting that it reports no new clinical results.

This article discusses treatment approaches for female pattern hair loss and concludes that available medical treatments are effective in reversing or stabilizing the condition in most cases of mild-to-moderate severity.

This study concluded that finasteride, cyproterone acetate, and flutamide were similarly effective at reducing hirsutism in women, though they acted through different mechanisms.

This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.

Genetics and hormones cause hair loss; finasteride treats it safely.

This review discusses the influence of androgens on hair and sebaceous growth, emphasizing that response may depend more on peripheral sensitivity than on hormone levels; it reports no new empirical results.

This study found that both finasteride and a regimen of cyproterone acetate plus ethinyl estradiol effectively reduced hirsutism in women, with similar results despite differing hormonal effects.

In this study, most hair disorders among HIV-1 positive patients were associated with low helper T cell counts, with papulosquamous conditions like seborrheic dermatitis and psoriasis being the most common.